SUDAN

1
SUDAN

• National Drug Policy
• Monitoring Antimalarial Resistance

2
National Drug Policy Monitoring Antimalarial
Resistance

• National Protocol for Malaria Treatment
• 1998 Workshop
• For Simple malaria
• CQ (tabs, Syp and Inj)
• SP
• Q, MQ
• For Severe malaria
• Q (IV)
• ART
• - Malaria and pregnancy

3
National Drug Policy Monitoring Antimalarial
Resistance

• Distribution
• - One booklet for each prescriber
• - One wall chart infront/behind each
  prescriber
• - 20,000 copies / 10,000 chart
• - Advocacy
• Sudan National Drug Policy
• - Removal of MQ, H
• - Stop registration of Artusnate (Monotherapy)

4
National Drug Policy Monitoring Antimalarial
Resistance

• Dr A. Bosman
• - Innovative protocol
• - CT
• Artusnate-based
• CQ SP
• Prof W. Wersnsdofer
• - Hospital-based Malarial Mortality Reduction
  Project

5
National Drug Policy Monitoring Antimalarial
Resistance

• 2002 Work
• 5 sites
• CQ in 5 sites
• SP in one site
• Other (Students)

6
National Drug Policy Monitoring Antimalarial
ResistanceResults of 2002 work
7
National Drug Policy Monitoring Antimalarial
Resistance

• In 2003
• New version of the treatment protocol (CQ SP)
• More studies (CT The best option)
• Free Treatment
• Technical assistance from WHO and others